Comparison of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Post Covid Fibrosis
Comparison of the Effectiveness of Pulmonary Telerehabilitation and Physical Activity Recommendations in Patients With Pulmonary Fibrosis Due to COVID-19
1 other identifier
interventional
30
1 country
1
Brief Summary
Rehabilitation plays a very important role in the management of patients with COVID-19, focusing on respiratory and motor functions, and therefore the importance of establishing treatment strategies to ensure optimal recovery of these patients has been emphasized. It has been stated that physical activity recommendations should be clarified for the management of symptoms associated with prolonged COVID-19 Syndrome and for the continuation of activities of daily living. It has been stated that after COVID-19 pneumonia, it is necessary to evaluate the physical functions of patients with long-term follow-up and to establish rehabilitation programs. The importance of being included in the rehabilitation program was emphasized, especially for patients with lung fibrosis. The primary aim of this study was to compare the effects of pulmonary telerehabilitation and physical activity recommendations on exercise capacity and peripheral muscle strength in patients with pulmonary fibrosis due to COVID-19. The secondary aim of this study is to compare the effects of pulmonary telerehabilitation and physical activity recommendations on symptoms, activity and participation in patients with pulmonary fibrosis due to COVID-19.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable covid19
Started Sep 2022
Longer than P75 for not_applicable covid19
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 25, 2022
CompletedFirst Posted
Study publicly available on registry
March 29, 2022
CompletedStudy Start
First participant enrolled
September 4, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 7, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 7, 2025
CompletedApril 4, 2025
February 1, 2024
2.5 years
March 25, 2022
April 1, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Submaximal exercise capacity
Six minute walk test and
1 week-8 week
maximal exercise capacity
Incremental shuttle walk test
1 week-8 week
endurance exercise capacity
endurance shuttle walk test
1 week-8 week
Peripheral muscle strength
Hand-held dynamometer
1 week-8 week
Secondary Outcomes (9)
Physical activity
1 week-8 week
Dyspnea
1 week-8 week
Fatigue
1 week-8 week
Physical fitness
1 week-8 week
Functionality
1 week-8 week
- +4 more secondary outcomes
Study Arms (2)
Pulmonary Rehabilitation Group
EXPERIMENTALA total of 24 sessions of breathing exercises and high-repetitive muscle endurance and strengthening exercises will be applied to the pulmonary telerehabilitation group for 8 weeks, two days a week and one day a week unsupervised, via online systems. High-repetition muscle endurance and strengthening exercises will be applied to large muscle groups of the lower and upper extremities by creating resistance with body weight and theraband.
Physical Activity Group
ACTIVE COMPARATORRespiratory exercises and physical activity recommendations will be given to the physical activity group. Physical activity recommendations are; It will include information about the importance of physical activity and walking 3-5 days a week for at least 30 minutes of moderate intensity (4-6 on the Modified Borg scale of perceived exertion level).
Interventions
High repetition muscle endurance and strengthening exercises Walking
Eligibility Criteria
You may qualify if:
- \>18 years old
- Patients who have been infected with the COVID-19 virus at least three months ago and have been diagnosed with a positive PCR
- Patients with post-COVID-19 pulmonary fibrosis followed by a pulmonologist
- Patients who have sufficient technological infrastructure to participate in the telerehabilitation program and can adapt to online systems
- Patients who are clinically stable
You may not qualify if:
- Patients with orthopedic/neurological problems that prevent walking and exercise
- Patients with uncontrolled cardiovascular disease
- Patients with uncontrolled medical conditions
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Istanbul University - Cerrahpasalead
- Health Institutes of Turkeycollaborator
Study Sites (1)
Istanbul University-Cerrahpasa
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Assistant
Study Record Dates
First Submitted
March 25, 2022
First Posted
March 29, 2022
Study Start
September 4, 2022
Primary Completion
March 7, 2025
Study Completion
March 7, 2025
Last Updated
April 4, 2025
Record last verified: 2024-02